tiprankstipranks
Align Tech (MX:ALGN)
:ALGN
Mexico Market
ALGN
Align Tech
RESEARCH TOOLSreports

Align Tech (ALGN) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

ALGN Analyst Ratings

Moderate Buy
12Ratings
Moderate Buy
8 Buy
3 Hold
1 Sell
Based on 12 analysts giving stock ratings to
Align
Tech
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ALGN Stock 12 Month Forecast

Average Price Target

$3,604.51
▲(20.15% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Align Tech in the last 3 months. The average price target is $3,604.51 with a high forecast of $4,052.96 and a low forecast of $3,174.82. The average price target represents a 20.15% change from the last price of $3,000.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2334":"$2,334","4053":"$4,053","2763.75":"$2,763.8","3193.5":"$3,193.5","3623.25":"$3,623.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":4052.95866,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$4.05K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3604.5062897499997,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$3.60K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3174.817617,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.17K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2334,2763.75,3193.5,3623.25,4053],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3000,3080.99682,3161.99364,3242.99046,3323.98728,3404.9840999999997,3485.98092,3566.97774,3647.9745599999997,3728.97138,3809.9682,3890.9650199999996,3971.96184,{"y":4052.95866,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3000,3046.500483826923,3093.000967653846,3139.501451480769,3186.0019353076923,3232.502419134615,3279.0029029615384,3325.5033867884613,3372.0038706153846,3418.5043544423074,3465.0048382692307,3511.5053220961536,3558.005805923077,{"y":3604.5062897499997,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3000,3013.447509,3026.895018,3040.3425270000002,3053.790036,3067.237545,3080.685054,3094.132563,3107.580072,3121.0275810000003,3134.47509,3147.922599,3161.370108,{"y":3174.817617,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2545,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2335,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2733,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2628,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2860,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2950,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3340,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3000,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3000,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2752.4,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2752.4,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3087.01,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3000,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$4,053Average Price Target$3,605Lowest Price Target$3,175
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
William Blair Analyst forecast on MX:ALGN
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
09/03/26
Analysts' Top Healthcare Picks: Align Tech (ALGN), Eledon Pharmaceuticals (ELDN)
Piper Sandler Analyst forecast on MX:ALGN
Jason Bednar
Piper Sandler
Piper Sandler
$3,968.52
Buy
32.28%
Upside
Reiterated
08/18/26
Piper Sandler Keeps Their Buy Rating on Align Tech (ALGN)
BMO Capital Analyst forecast on MX:ALGN
Vik Chopra
BMO Capital
BMO Capital
$3,529.45
Buy
17.65%
Upside
Reiterated
08/12/26
Align Technology: Buy Rating Reiterated on Strengthening Legal Moat and Recovery Prospects; $209 Price Target Maintained
Evercore ISI Analyst forecast on MX:ALGN
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$3,715.21
Buy
23.84%
Upside
Reiterated
08/10/26
Analysts Are Bullish on These Healthcare Stocks: Gyre Therapeutics (GYRE), Align Tech (ALGN)
Barclays Analyst forecast on MX:ALGN
Glen Santangelo
Barclays
Barclays
$3,377.47
Buy
12.58%
Upside
Reiterated
08/05/26
Analysts' Top Healthcare Picks: Syndax Pharmaceuticals (SNDX), Align Tech (ALGN)
Citi Analyst forecast on MX:ALGN
Daniel Grosslight
Citi
Citi
$4,052.96
Buy
35.10%
Upside
Reiterated
08/03/26
Align Tech (ALGN) Receives a Buy from Citi
Morgan Stanley Analyst forecast on MX:ALGN
Erin Wright
Morgan Stanley
Morgan Stanley
$3,174.82
Hold
5.83%
Upside
Reiterated
07/30/26
Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (NASDAQ: AMLX), Heart Test Laboratories, Inc. (NASDAQ: HSCS) and Align Tech (NASDAQ: ALGN)
Bank of America Securities Analyst forecast on MX:ALGN
Michael Ryskin
Bank of America Securities
Bank of America Securities
―
Sell
―
Reiterated
07/30/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Takeda Pharmaceutical Company (NYSE: TAK), Align Tech (NASDAQ: ALGN) and Conmed (NYSE: CNMD)
Stifel Nicolaus Analyst forecast on MX:ALGN
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
$3,546.34
Buy
18.21%
Upside
Reiterated
07/30/26
Stifel Nicolaus Keeps Their Buy Rating on Align Tech (ALGN)
Needham Analyst forecast on MX:ALGN
David Saxon
Needham
Needham
―
Hold
―
Reiterated
07/30/26
Align Technology: Hold Rating Maintained as Systems Weakness Caps Near-Term Upside Despite Solid Clear Aligner Performance and Reaffirmed 2026 Outlook
UBS Analyst forecast on MX:ALGN
Kevin Caliendo
UBS
UBS
$3,141.04→$3,191.7
Hold
6.39%
Upside
Reiterated
07/23/26
Align Technology price target raised to $189 from $186 at UBSAlign Technology price target raised to $189 from $186 at UBS
Leerink Partners Analyst forecast on MX:ALGN
Michael Cherny
Leerink Partners
Leerink Partners
$3,546.34→$3,884.09
Buy
29.47%
Upside
Reiterated
06/30/26
EU case likely won't have much fundamental impact on Align, says LeerinkEU case likely won't have much fundamental impact on Align, says Leerink
Mizuho Securities Analyst forecast on MX:ALGN
Steven Valiquette
Mizuho Securities
Mizuho Securities
$3,630.78→$3,715.21
Buy
23.84%
Upside
Reiterated
04/30/26
Align Tech (ALGN) Gets a Buy from Mizuho Securities
HSBC Analyst forecast on MX:ALGN
Sidharth Sahoo
HSBC
HSBC
$2,533.1→$3,377.47
Buy
12.58%
Upside
Upgraded
02/09/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Robert W. Baird Analyst forecast on MX:ALGN
Jeff Johnson
Robert W. Baird
Robert W. Baird
$3,461.9→$3,681.44
Buy
22.71%
Upside
Reiterated
02/05/26
Align Technology price target raised to $218 from $205 at BairdAlign Technology price target raised to $218 from $205 at Baird
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
William Blair Analyst forecast on MX:ALGN
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
09/03/26
Analysts' Top Healthcare Picks: Align Tech (ALGN), Eledon Pharmaceuticals (ELDN)
Piper Sandler Analyst forecast on MX:ALGN
Jason Bednar
Piper Sandler
Piper Sandler
$3,968.52
Buy
32.28%
Upside
Reiterated
08/18/26
Piper Sandler Keeps Their Buy Rating on Align Tech (ALGN)
BMO Capital Analyst forecast on MX:ALGN
Vik Chopra
BMO Capital
BMO Capital
$3,529.45
Buy
17.65%
Upside
Reiterated
08/12/26
Align Technology: Buy Rating Reiterated on Strengthening Legal Moat and Recovery Prospects; $209 Price Target Maintained
Evercore ISI Analyst forecast on MX:ALGN
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$3,715.21
Buy
23.84%
Upside
Reiterated
08/10/26
Analysts Are Bullish on These Healthcare Stocks: Gyre Therapeutics (GYRE), Align Tech (ALGN)
Barclays Analyst forecast on MX:ALGN
Glen Santangelo
Barclays
Barclays
$3,377.47
Buy
12.58%
Upside
Reiterated
08/05/26
Analysts' Top Healthcare Picks: Syndax Pharmaceuticals (SNDX), Align Tech (ALGN)
Citi Analyst forecast on MX:ALGN
Daniel Grosslight
Citi
Citi
$4,052.96
Buy
35.10%
Upside
Reiterated
08/03/26
Align Tech (ALGN) Receives a Buy from Citi
Morgan Stanley Analyst forecast on MX:ALGN
Erin Wright
Morgan Stanley
Morgan Stanley
$3,174.82
Hold
5.83%
Upside
Reiterated
07/30/26
Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (NASDAQ: AMLX), Heart Test Laboratories, Inc. (NASDAQ: HSCS) and Align Tech (NASDAQ: ALGN)
Bank of America Securities Analyst forecast on MX:ALGN
Michael Ryskin
Bank of America Securities
Bank of America Securities
―
Sell
―
Reiterated
07/30/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Takeda Pharmaceutical Company (NYSE: TAK), Align Tech (NASDAQ: ALGN) and Conmed (NYSE: CNMD)
Stifel Nicolaus Analyst forecast on MX:ALGN
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
$3,546.34
Buy
18.21%
Upside
Reiterated
07/30/26
Stifel Nicolaus Keeps Their Buy Rating on Align Tech (ALGN)
Needham Analyst forecast on MX:ALGN
David Saxon
Needham
Needham
―
Hold
―
Reiterated
07/30/26
Align Technology: Hold Rating Maintained as Systems Weakness Caps Near-Term Upside Despite Solid Clear Aligner Performance and Reaffirmed 2026 Outlook
UBS Analyst forecast on MX:ALGN
Kevin Caliendo
UBS
UBS
$3,141.04→$3,191.7
Hold
6.39%
Upside
Reiterated
07/23/26
Align Technology price target raised to $189 from $186 at UBSAlign Technology price target raised to $189 from $186 at UBS
Leerink Partners Analyst forecast on MX:ALGN
Michael Cherny
Leerink Partners
Leerink Partners
$3,546.34→$3,884.09
Buy
29.47%
Upside
Reiterated
06/30/26
EU case likely won't have much fundamental impact on Align, says LeerinkEU case likely won't have much fundamental impact on Align, says Leerink
Mizuho Securities Analyst forecast on MX:ALGN
Steven Valiquette
Mizuho Securities
Mizuho Securities
$3,630.78→$3,715.21
Buy
23.84%
Upside
Reiterated
04/30/26
Align Tech (ALGN) Gets a Buy from Mizuho Securities
HSBC Analyst forecast on MX:ALGN
Sidharth Sahoo
HSBC
HSBC
$2,533.1→$3,377.47
Buy
12.58%
Upside
Upgraded
02/09/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Robert W. Baird Analyst forecast on MX:ALGN
Jeff Johnson
Robert W. Baird
Robert W. Baird
$3,461.9→$3,681.44
Buy
22.71%
Upside
Reiterated
02/05/26
Align Technology price target raised to $218 from $205 at BairdAlign Technology price target raised to $218 from $205 at Baird
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ONCBeOne Medicines
DNLIDenali Therapeutics
SNDXSyndax Pharmaceuticals
ZYMEZymeworks
PTGXProtagonist Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Align Tech

3 Months
Steven ValiquetteMizuho Securities
Success Rate
13/22 ratings generated profit
59%
Average Return
+10.98%
Copying Steven Valiquette's trades and holding each position for 3 Months would result in 59.09% of your transactions generating a profit, with an average return of +10.98% per trade.
1 Year
Michael RyskinBank of America Securities
Success Rate
18/23 ratings generated profit
78%
Average Return
+2.07%
Copying Michael Ryskin's trades and holding each position for 1 Year would result in 78.26% of your transactions generating a profit, with an average return of +2.07% per trade.
2 Years
Michael RyskinBank of America Securities
Success Rate
21/23 ratings generated profit
91%
Average Return
+20.80%
Copying Michael Ryskin's trades and holding each position for 2 Years would result in 91.30% of your transactions generating a profit, with an average return of +20.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ALGN Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
0
0
0
0
0
Buy
18
21
19
17
13
Hold
5
5
6
4
4
Sell
2
2
2
1
1
Strong Sell
0
0
0
0
0
total
25
28
27
22
18
In the current month, ALGN has received 13 Buy Ratings, 4 Hold Ratings, and 1 Sell Ratings. ALGN average Analyst price target in the past 3 months is 3,604.51.
Each month's total comprises the sum of three months' worth of ratings.

ALGN Financial Forecast

ALGN Earnings Forecast

Next quarter’s earnings estimate for ALGN is $47.47 with a range of $46.35 to $48.89. The previous quarter’s EPS was $44.82. ALGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ALGN has Performed in-line its overall industry.
Next quarter’s earnings estimate for ALGN is $47.47 with a range of $46.35 to $48.89. The previous quarter’s EPS was $44.82. ALGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ALGN has Performed in-line its overall industry.

ALGN Sales Forecast

Next quarter’s sales forecast for ALGN is $17.23B with a range of $17.05B to $17.59B. The previous quarter’s sales results were $17.93B. ALGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ALGN has Performed in-line its overall industry.
Next quarter’s sales forecast for ALGN is $17.23B with a range of $17.05B to $17.59B. The previous quarter’s sales results were $17.93B. ALGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ALGN has Performed in-line its overall industry.

ALGN Stock Forecast FAQ

What is MX:ALGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Align Tech’s 12-month average price target is 3,604.51.
    What is MX:ALGN’s upside potential, based on the analysts’ average price target?
    Align Tech has 20.15% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Align Tech a Buy, Sell or Hold?
          Align Tech has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 3 hold ratings and 1 sell ratings.
            What is Align Tech’s share price target?
            The average share price target for Align Tech is 3,604.51. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $4,052.96 ,and the lowest forecast is $3,174.82. The average share price target represents 20.15% Increase from the current price of $3,000.
              What do analysts say about Align Tech?
              Align Tech’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of Align Tech?
                To buy shares of MX:ALGN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.